🔎 Trials Near Me

Utama › Limfoma › New Jersey › Edison

Kajian klinikal Limfoma di Edison, NJ

12 kajian untuk Limfoma sedang mencari peserta di lokasi dalam dan sekitar Edison (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Rutgers University Study of the Genetics of Blood Cancers

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Rutgers University, Piscataway · 2 mi jauh
Umur 18 hingga 110 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07714044

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Mengambil pesertaFasa 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07015242

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT02974647

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Mengambil pesertaFasa 1
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT04301076

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Mengambil pesertaFasa 3
  • Research Site, Basking Ridge · 15 mi jauh
Umur 18 hingga 18 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07509151

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

Mengambil pesertaFasa 3
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06084936

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge · 15 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT05389293

A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

Mengambil pesertaFasa 1
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Jun 2026 · NCT07137494

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Mengambil pesertaSukarelawan sihat dialu-alukan
  • Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge · 15 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Mei 2026 · NCT07052916

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering at Basking Ridge (All protocol activities), Basking Ridge · 15 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mac 2026 · NCT06698003

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

Mengambil pesertaKajian pemerhatian
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauh
Umur 18 ke atas · Wanita · Dikemas kini 4 Mac 2026 · NCT01788839

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauh
Semua umur · Semua jantina · Dikemas kini 23 Jan 2026 · NCT00582621

Kajian Limfoma di bandar lain

Kajian lain di Edison

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.